Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
Clinical trial NCT02859064 · TERMINATED
Trial details
- NCT number
- NCT02859064
- Sponsor
- SCRI Development Innovations, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-28
- Primary completion
- 2022-05-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.